Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
The tools of disability outcomes research functional status measures
2000 Standout
What contributes to depression in Parkinson's disease?
2001
Heparin-Protein Interactions
2002 Standout
Intracellular degradation of secretion defect‐type mutants of antithrombin is inhibited by proteasomal inhibitors
1997 StandoutNobel
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats
2005
Heparin-induced thrombocytopenia
1996
Clinical problems in non-fluctuating patients with Parkinson's disease: A community-based study
2000
Ulcerative Colitis
2011 Standout
Probiotic‐induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory‐dependent mechanisms in a murine model of asthma
2006
Herb-drug interactions
2000 Standout
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease
2006
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
2000 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
A systematic review of prevalence studies of depression in Parkinson's disease
2007 Standout
The molecular basis of blood coagulation
1988 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor
1988
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
1995 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Postdischarge Care and Readmissions
1988
Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease
2004
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis
2013
Ulcerative colitis
2012 Standout
Worldwide Prevalence and Incidence of Dementia
1999
Probiotics and clinical effects: is the number what counts?
2013
Burden of Caregivers of People with Stroke: Evolution and Predictors
2009
Heparin-Induced Thrombocytopenia
2006 Standout
The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease
2006
Intestinal mucosal barrier function in health and disease
2009 Standout
Malignant Gliomas in Adults
2008 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Ulcerative colitis
2016 Standout
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
2005
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Depression in Parkinson's disease: clinical correlates and outcome
2003
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
Alzheimer's Disease
2004 Standout
A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure
1995 Standout
Dietary Supplements and Natural Products as Psychotherapeutic Agents
1999
Cognitive and Motor Function in Patients with Parkinson's Disease with and without Depression
2000
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
The pros, cons, and many unknowns of probiotics
2019 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Heparin‐induced thrombocytopenia: A prospective study
1984
Biosensing with plasmonic nanosensors
2008 Standout
Gut Microbiota in Health and Disease
2010 Standout
The role of neurotransmitters in the development of Parkinson's disease‐related psychosis
2017
Isolation and characterization of urokinase from human plasma.
1982
Serpin Structure, Mechanism, and Function
2002 Standout
Prevalence and Treatment of Depression in Parkinson’s Disease
2005
Hypercoagulability and thrombosis
1994
Antithrombin III Deficiency and Thromboembolism
1981
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Caregiver Burden
2014 Standout
Plasminogen activator from human embryonic kidney cell cultures
1977
Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
1977
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Depression et Maladie de Parkinson: étude d’une série de 135 parkinsoniens
2002
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen
1979
Purification and properties of human coagulation factor VII.
1980
Depression is associated with impairment of ADL, not motor function in Parkinson disease
2005
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The Size and Shape of Human and Bovine Antithrombin III
1977
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma Virus
1982
Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate
1980
Partial NH2- and cooh-terminal sequence analyses of Eco RI DNA restriction and modification enzymes.
1981 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
1978
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone
1979
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
Complementary and Alternative Medicines for Alzheimer's Disease
1998
The purification of a human plasma kallikrein with weak plasminogen activator activity
1978
Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.
1976
Thrombocytopenia in a Prospective, Randomized, Double-Blind Trial of Bovine and Porcine Heparin
1984
Nanostructures in Biodiagnostics
2005 Standout
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
2005
Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin
1977
Heparin-Associated Thrombocytopenia
1984
Secretory products of macrophages.
1987 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
Binding of human factor VII and VIIa to monocytes.
1982
Organophosphate detoxicating hydrolases in different vertebrate species
1983
Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes Project
2004
Comparative Studies on Human Activators of Plasminogen
1981
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Heparin-Associated Thrombocytopenia: A Prospective Comparison of Bovine Lung Heparin, Manufactured by a New Process, and Porcine Intestinal Heparin
1986
A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen
1983
Works of K Laake being referenced
Drug use and medication non-compliance in patients discharged from a medical ward.
1981
Acute Phase Predictors of Subsequent Psychosocial Burden in Carers of Elderly Stroke Patients
2001
Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis
2005
Risk Factors for Depression in Parkinson Disease
1997
No identifiable effect of ginseng (Gericomplex) as an adjuvant in the treatment of geriatric patients
1996
Accuracy of CT scan measurements of the medial temporal lobe in routine dementia diagnostics
2003
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-Configurated ileal-pouch-anal-anastomosis (IPAA)
2004
The Barthel ADL Index: Factor Structure depends upon the Category of Patient
1995
Progressive inactivation of factor VII in the cold by heparin
1974
Reactions between alkyl phosphates and acetylcholinesterase from different species
1972
Factor XII-induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma
1974
Inactivation and binding of human plasma kallikrein by antithrombin III and heparin
1976
THROMBOCYTES AND TREATMENT WITH HEPARIN FROM PORCINE MUCOSA
1980
Low Incidence of Thrombocytopenia during Treatment with Hog Mucosa and Beef Lung Heparin
1981
Progressive inactivation of purified factor VII by heparin and antithrombin III
1974
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction
2020
Purification and some characteristics of factor VII in human citrated plasma, glass-activated serum, and cold-activated plasma
1974
Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative Colitis
2003
Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system
1974
Prevalence of dementia in a Norwegian sample aged 75 years and over and living at home.
1988
[Ginseng--no identifiable effect in geriatric rehabilitation].
1997